One or multiple inhalers plus app support for COPD
Part of Lungs & breathing clinical trials.
This trial looks at whether using one or more inhalers, together with a smartphone app, can help people manage chronic obstructive pulmonary disease (COPD) better. You may be eligible if you have COPD, need “triple therapy” (three medicine types), and can use the app and surveys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve been diagnosed with COPD for at least 1 year
- You are age 40 or older
- A doctor says you need triple therapy (either stepping up from two inhalers or already on three)
- You currently smoke or used to smoke (current or ex-smoker)
- You have a smartphone (Android or iPhone) with internet and can use the app
- You can read Dutch well enough to use the app (family help is allowed), and you can complete questionnaires
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a once-daily inhaler that combines a long-acting bronchodilator with a corticosteroid to see if it improves breathing, lung function, and quality of life in people with moderate-to-severe COPD who have significant shortness of breath.
This study tests a smartphone app designed to help you track and manage your COPD symptoms day-to-day. It includes a small device you use at home to measure your lung function, aiming to help you catch problems early and stay healthier.
This study tests a smartphone app that helps you learn or improve how to use your inhaler correctly. The app provides education and training to make sure you get the most from your medication.
This trial tests a structured review process to help people with COPD who have needed multiple steroid pills in the past year. It aims to improve care and prevent future harm from the condition.
This study looks at how well the myCOPD app can spot when a patient's current medication isn't working well for their symptoms. If the app finds a possible issue, it may suggest a review with a clinician. This could help you get better symptom control.
This study tests a new combination inhaler (fluticasone, formoterol, and glycopyrronium) for people with COPD. It aims to see if this triple therapy can improve breathing and quality of life compared to current treatments.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.